Skip to content
10-Q

Quarterly Report

Talis Biomedical Corporation

0000950170-23-063371

← back to feed
Filed
Nov 14, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 8, 2023 3.81M sh
Shares Diluted Q3 2023 · Sep 30, 2023 1.82M sh
Shares Diluted Q3 2023 · Sep 30, 2023 1.82M sh
Shares Diluted restated Q3 2023 · Sep 30, 2022 1.8M sh
Shares Diluted restated Q3 2023 · Sep 30, 2022 1.8M sh
Capex Q3 2023 · Sep 30, 2023 $579K
Capex Q3 2023 · Sep 30, 2022 $1.57M
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$41.88M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$86.59M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $88M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $130.19M
Cash And Equivalents Q3 2023 · Sep 30, 2022 $143.78M
Stockholders Equity Q3 2023 · Sep 30, 2023 $81.56M
Stockholders Equity Q3 2023 · Jun 30, 2023 $96.17M
Stockholders Equity Q3 2023 · Mar 31, 2023 $110.12M
Stockholders Equity Q3 2023 · Dec 31, 2022 $126.74M
Stockholders Equity Q3 2023 · Sep 30, 2022 $152.39M
Stockholders Equity Q3 2023 · Jun 30, 2022 $177.02M
Stockholders Equity Q3 2023 · Mar 31, 2022 $202.79M
Stockholders Equity Q3 2023 · Dec 31, 2021 $233.98M
Current Liabilities Q3 2023 · Sep 30, 2023 $8.45M
Current Liabilities Q3 2023 · Dec 31, 2022 $12.67M
Total Liabilities Q3 2023 · Sep 30, 2023 $25.67M
Total Liabilities Q3 2023 · Dec 31, 2022 $42.55M
Current Assets Q3 2023 · Sep 30, 2023 $89.53M
Current Assets Q3 2023 · Dec 31, 2022 $133.28M
Total Assets Q3 2023 · Sep 30, 2023 $107.23M
Total Assets Q3 2023 · Dec 31, 2022 $169.29M
Eps Diluted Q3 2023 · Sep 30, 2023 −$8.62
Eps Diluted Q3 2023 · Sep 30, 2023 −$26.73
Eps Diluted restated Q3 2023 · Sep 30, 2022 −$14.44
Eps Diluted restated Q3 2023 · Sep 30, 2022 −$47.91
Eps Basic Q3 2023 · Sep 30, 2023 −$8.62
Eps Basic Q3 2023 · Sep 30, 2023 −$26.73
Eps Basic restated Q3 2023 · Sep 30, 2022 −$14.44
Eps Basic restated Q3 2023 · Sep 30, 2022 −$47.91
Sga Expense Q3 2023 · Sep 30, 2023 $8.8M
Sga Expense Q3 2023 · Sep 30, 2023 $21.61M
Sga Expense Q3 2023 · Sep 30, 2022 $8.83M
Sga Expense Q3 2023 · Sep 30, 2022 $29.93M
Rd Expense Q3 2023 · Sep 30, 2023 $8.3M
Rd Expense Q3 2023 · Sep 30, 2023 $32.65M
Rd Expense Q3 2023 · Sep 30, 2022 $17.52M
Rd Expense Q3 2023 · Sep 30, 2022 $55.59M
Net Income Q3 2023 · Sep 30, 2023 −$15.68M
Net Income Q3 2023 · Sep 30, 2023 −$48.55M
Net Income Q3 2023 · Jun 30, 2023 −$15.03M
Net Income Q3 2023 · Mar 31, 2023 −$17.83M
Net Income Q3 2023 · Sep 30, 2022 −$26.02M
Net Income Q3 2023 · Sep 30, 2022 −$86.08M
Net Income Q3 2023 · Jun 30, 2022 −$27.01M
Net Income Q3 2023 · Mar 31, 2022 −$33.05M
Operating Income Q3 2023 · Sep 30, 2023 −$16.97M
Operating Income Q3 2023 · Sep 30, 2023 −$52.36M
Operating Income Q3 2023 · Sep 30, 2022 −$26.79M
Operating Income Q3 2023 · Sep 30, 2022 −$87.03M
Cost Of Revenue Q3 2023 · Sep 30, 2023 $6K
Cost Of Revenue Q3 2023 · Sep 30, 2023 $33K
Cost Of Revenue Q3 2023 · Sep 30, 2022 $1.24M
Cost Of Revenue Q3 2023 · Sep 30, 2022 $6.06M
Revenue Q3 2023 · Sep 30, 2023 $140K
Revenue Q3 2023 · Sep 30, 2023 $1.94M
Revenue Q3 2023 · Sep 30, 2022 $796K
Revenue Q3 2023 · Sep 30, 2022 $4.56M